Pharma & Biotech

Pharmaceutical giant AbbVie is demonstrating strategic agility as it shifts resources toward promising growth areas while exiting less productive ventures....

The investment community finds itself deeply divided over Biogen's prospects, creating a compelling narrative of contrasting viewpoints. As market experts...

Shares of Viking Therapeutics reached their highest point in ten months during Wednesday's trading session, continuing a significant upward trend....

Biotechnology leader Amgen is experiencing a significant rally, propelled by a powerful combination of exceptional financial performance and a major...

The pharmaceutical giant's intensified focus on cancer research is yielding tangible results. Bristol-Myers Squibb is advancing its oncology pipeline through...

The survival of biotechnology firm Novavax hangs in the balance as activist investor Shah Capital escalates pressure on the company's...

Ocugen, Inc. witnessed a sharp 7% decline in its share price on Wednesday, a downturn driven by investor apprehension over...

Eli Lilly and Company has launched a remarkable strategic initiative, announcing three major transactions worth billions of dollars within days....

The proposed multi-billion euro acquisition of CureVac by BioNTech enters its final phase with two crucial November deadlines approaching. Shareholders...

Shares of Viking Therapeutics experienced significant upward momentum this week, fueled by renewed takeover speculation and a positive analyst update....